Paper Details
- Home
- Paper Details
Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany.
Author: Abdel-HamidMona, EberhardSveja, HessmannPhilipp, KisBernhard, StahmeyerJona, VogelgsangJonathan, WiltfangJens, Wolff-MenzlerClaus, ZeidlerJan
Original Abstract of the Article :
<b>Objective:</b> A restrictive use of tricyclic antidepressants (TCA) in patients with dementia (PwD) is recommended due to the hazard of anticholinergic side effects. We evaluated the frequency of TCA dispensing in PwD over a period of 1 year and the use of TCA before and after the incident diagn...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667932/
データ提供：米国国立医学図書館（NLM）
Tricyclic Antidepressants in Dementia: A Data Analysis
The management of dementia presents a unique set of challenges, much like navigating a vast and unfamiliar desert. This study examines the dispensing of tricyclic antidepressants (TCAs) among patients with dementia in Germany, utilizing administrative data from a statutory health insurance. The researchers meticulously analyzed data from 20,357 patients with an incident diagnosis of dementia, focusing on the frequency of TCA dispensing in 2015. They found that 5.5% of these patients received TCA treatment during that year, with amitriptyline, doxepin, and trimipramine being the most commonly dispensed medications. The study highlights the need for improved adherence to guidelines regarding TCA use in dementia patients, given their potential for anticholinergic side effects.
Navigating the Use of TCAs
The study highlights the need for careful consideration when using TCAs in patients with dementia. While TCAs may be effective in treating depression, their potential for anticholinergic side effects raises concerns, particularly in individuals with cognitive impairment. This emphasizes the importance of balancing potential benefits with potential risks, much like a desert traveler would carefully assess the terrain before embarking on a journey.
A Call for Personalized Care
The study underscores the importance of personalized care for dementia patients, particularly when considering pharmacotherapy. It emphasizes the need for careful evaluation and monitoring to ensure that treatment options are tailored to individual needs and risk profiles.
Dr.Camel's Conclusion
This study highlights the complex interplay between medication use and dementia management. It emphasizes the need for careful consideration of potential risks and benefits when using TCAs in dementia patients and underscores the importance of personalized care and adherence to guidelines to ensure optimal patient safety and well-being.
Date :
- Date Completed n.d.
- Date Revised 2020-10-01
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.